CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to CRBP

CRB-601 monoclonal antibody

Phase 2
Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Phase 2

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Nov '26
CRBPPhase 2

CRB-601 monoclonal antibody Phase 2 Est. Readout

CRB-601 monoclonal antibody
Nov 2026~
CT.gov
00%
Drug Information

Target Indication

Solid Tumor

Clinical Trial

NCT06603844

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.